326 related articles for article (PubMed ID: 17970638)
1. The hypocretin/orexin receptor: therapeutic prospective in sleep disorders.
Nishino S
Expert Opin Investig Drugs; 2007 Nov; 16(11):1785-97. PubMed ID: 17970638
[TBL] [Abstract][Full Text] [Related]
2. Orexin receptors: pharmacology and therapeutic opportunities.
Scammell TE; Winrow CJ
Annu Rev Pharmacol Toxicol; 2011; 51():243-66. PubMed ID: 21034217
[TBL] [Abstract][Full Text] [Related]
3. Hypocretin antagonists in insomnia treatment and beyond.
Ruoff C; Cao M; Guilleminault C
Curr Pharm Des; 2011; 17(15):1476-82. PubMed ID: 21476951
[TBL] [Abstract][Full Text] [Related]
4. The hypocretin/orexin system in health and disease.
Nishino S
Biol Psychiatry; 2003 Jul; 54(2):87-95. PubMed ID: 12873797
[TBL] [Abstract][Full Text] [Related]
5. Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog.
Fujiki N; Yoshida Y; Ripley B; Mignot E; Nishino S
Sleep; 2003 Dec; 26(8):953-9. PubMed ID: 14746374
[TBL] [Abstract][Full Text] [Related]
6. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
7. Drugs to interfere with orexins (hypocretins).
Selbach O; Eriksson KS; Haas HL
Drug News Perspect; 2003 Dec; 16(10):669-81. PubMed ID: 14747847
[TBL] [Abstract][Full Text] [Related]
8. Hypocretin ligand deficiency in narcolepsy: recent basic and clinical insights.
Ritchie C; Okuro M; Kanbayashi T; Nishino S
Curr Neurol Neurosci Rep; 2010 May; 10(3):180-9. PubMed ID: 20425033
[TBL] [Abstract][Full Text] [Related]
9. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
[TBL] [Abstract][Full Text] [Related]
10. Emerging treatments for narcolepsy and its related disorders.
Nishino S; Okuro M
Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
[TBL] [Abstract][Full Text] [Related]
11. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
Zeitzer JM; Nishino S; Mignot E
Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
[TBL] [Abstract][Full Text] [Related]
12. Role of the hypocretin (orexin) receptor 2 (Hcrt-r2) in the regulation of hypocretin level and cataplexy.
Wu MF; Nienhuis R; Maidment N; Lam HA; Siegel JM
J Neurosci; 2011 Apr; 31(17):6305-10. PubMed ID: 21525270
[TBL] [Abstract][Full Text] [Related]
13. [Involvement of orexins/hypocretins in multiple physiological functions].
Ueta Y
J UOEH; 2001 Jun; 23(2):147-59. PubMed ID: 11431960
[TBL] [Abstract][Full Text] [Related]
14. Orexin receptor antagonists: medicinal chemistry and therapeutic potential.
Roecker AJ; Coleman PJ
Curr Top Med Chem; 2008; 8(11):977-87. PubMed ID: 18673167
[TBL] [Abstract][Full Text] [Related]
15. Hypocretin and its emerging role as a target for treatment of sleep disorders.
Cao M; Guilleminault C
Curr Neurol Neurosci Rep; 2011 Apr; 11(2):227-34. PubMed ID: 21170610
[TBL] [Abstract][Full Text] [Related]
16. The orexin story, sleep and sleep disturbances.
Pizza F; Barateau L; Dauvilliers Y; Plazzi G
J Sleep Res; 2022 Aug; 31(4):e13665. PubMed ID: 35698789
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptides as possible targets in sleep disorders: special emphasis on hypocretin-deficient narcolepsy.
Fujiki N; Nishino S
CNS Neurol Disord Drug Targets; 2007 Feb; 6(1):45-62. PubMed ID: 17305553
[TBL] [Abstract][Full Text] [Related]
18. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
Hoyer D; Jacobson LH
Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
[TBL] [Abstract][Full Text] [Related]
19. Orexins and orexin receptors: from molecules to integrative physiology.
Matsuki T; Sakurai T
Results Probl Cell Differ; 2008; 46():27-55. PubMed ID: 18204827
[TBL] [Abstract][Full Text] [Related]
20. Emerging drugs for narcolepsy.
Abad VC; Guilleminault C
Expert Opin Emerg Drugs; 2004 Nov; 9(2):281-91. PubMed ID: 15571485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]